Clinical Trial Update: Deferiprone to Delay Dementia (The 3D Study) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on using deferiprone to delay dementia in individuals with Mild Cognitive Impairment or prodromal Alzheimer's disease; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 | Status: COMPLETED